This contrasts with the findings of Tison et al. (24), who found that an algorithm using more than one heart failure code plus any heart failure medication offered only 67.2% sensitivity, decreasing further when elevated NT-proBNP was included. The gene discussed is NPPB; the disease is heart failure.